COST INDEX
Tirz yr-one floor $139✓ audSema yr-one floor $119✓ audAbsolute floor · micro $110✓ audFifty 410 prepay ~$133on recHims w/ 12-mo term ~$165on recHenry no-term ~$149on recMochi $79+medon recAltRx promo door ~$89on recRemedy promo door $99→on recShedRx entry ~$199on recZepbound vial $349shelfWegovy self-pay $499shelf
VSCompareGLP1ProvidersYEAR-ONE MATH · LIVE-CHECKOUT AUDITSFind my program →

Pricing forensics · from the 250-topic plan

The two-line price: membership-model forensics

THE SHORT ANSWER

The membership model splits one price into two lines — a headline membership fee and a medication charge billed separately — and the forensic point is what typically happens to line two: it lives off the pricing page. Our field's cleanest specimen advertises a $79/month membership with medication billed separately at rates the membership page doesn't state — which makes the famous number a fraction with a hidden denominator. This piece explains why the architecture exists, when a two-line model can actually be fair, the totaling method that makes any of them comparable, and the one written question that collapses the whole structure into a real price.

The architecture, drawn plainly

Line one: the membership — access, “care,” platform, sometimes consults — priced low, advertised loudly, and technically true. Line two: the medication — the thing you came for — billed separately, often quoted only inside the funnel, sometimes varying by molecule, dose, or pharmacy routing. The advertised number is real and the total is unknowable from the ad, which is not an accident of web design; it is the design. Our on-record specimen: a $79/month membership headline with medication as a separate, page-absent line — the model in its purest form, filed accordingly as an open item rather than a ranked total in the dataset.

Why programs build it

Three rational reasons, none of them about your clarity. The anchor: $79 competes in headlines against $199s and $299s it isn't actually comparable to — an apples-to-orchards comparison the shopper performs on the seller's behalf. The churn cushion: membership revenue persists through medication pauses, holds, and switches — the business keeps billing while the therapy breathes. The comparison shield: a price that doesn't exist on any page can't be put in anyone's comparison table — including ours, which is why this article exists instead of a row.

When two lines can actually be fair

Honesty cuts both ways: unbundling isn't inherently a trick. A two-line model earns legitimacy when line two is published, stable, and dose-transparent — a stated medication price list, visible before signup, with the membership buying genuinely optional services a patient might value. Under those conditions the structure is just itemization. The forensic test is therefore not “is there a membership?” but “can I compute my year from public pages?” — the same computability standard every model on this site is held to, from qualifier pricing to promo doors.

The totaling method

To compare any membership model against all-in pricing: (membership × 12) + (maintenance-dose medication price × 12) + stated fees — insisting on the maintenance-dose figure, per the ladder piece, and refusing to substitute hope for the missing line. Worked against the field: even a hypothetical $79 membership pairs with a $100/month medication line to a $2,148 year — landing above the audited all-in flats of $1,668/$1,428 — and every $25 of unpublished medication price moves the total $300/year. A fraction with a hidden denominator can equal anything, which is precisely why we don't rank it and do teach it. The one-line benchmark ↗

The collapsing question

In writing, before paying: “At my maintenance dose, what is the exact monthly medication charge — and may I see the full price list the membership page doesn't show?” A fair two-line program answers with a list and survives the totaling method. A structural two-line program answers with “it depends” — and “it depends” from a seller who chose the architecture is a complete answer, just not to your question.

FAQ

Why do some GLP-1 programs charge a membership plus medication?

The structure anchors a low headline, keeps revenue through medication pauses, and shields the true total from comparison — though it can be legitimate itemization when the medication price list is published and stable.

How do I compare a membership model to all-in pricing?

(Membership × 12) + (maintenance-dose medication price × 12) + fees — refusing to proceed without the medication line in writing; unknowable lines make unrankable totals.

Is a $79/month GLP-1 membership actually cheap?

Unanswerable until line two exists: even modest separate medication pricing lifts such models above the audited $1,428–$1,668 all-in years, and every unpublished $25/month is $300/year of uncertainty.

Sources

  • On-record membership-model pricing in the field — the open dataset, filed as open where medication lines are unpublished.
  • FTC guidance on total-cost disclosure and drip pricing.
  • Audited all-in benchmarks, verified 2026-08-14.
SECOND VISIT?

Stop re-reading tabs — answer three questions and the field sorts itself. No email, no account.

Sort the field for me →